Investing in biotech stocks isn't for everyone because the very nature of their business is fraught with risk. As a result, ...

The stock's fall snapped a two-day winning streak.

This was the stock's second consecutive day of gains.

Jefferies has upgraded Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), citing the company’s robust cystic fibrosis base business ...

Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of ...

In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The company’s ...

Fintel reports that on December 9, 2024, Jefferies upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from ...

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $469.29, indicating a -0.99% shift from the previous trading day.

Two Saudi Arabian agencies signed on with Vertex Pharmaceuticals to help boost the countr | The Vertex agreement is part of ...

In a report released today, Michael Yee from Jefferies upgraded Vertex Pharmaceuticals (VRTX – Research Report) to a Buy, with a price target ...

Vertex Pharmaceuticals (VRTX) presented positive long-term data for its gene therapy Casgevy and issued a business update on ...

Saudi Arabia’s Ministry of Industry and Mineral Resources signed a memorandum of understanding (MoU) with US-based Vertex ...